Cardiol Therapeutics (CRDL) News Today → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free CRDL Stock Alerts C$3.15 +0.20 (+6.78%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:26 PM | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)May 10, 2024 | baystreet.caManufacturing, Housing Due Next Week in CanadaApril 30, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading 12.9% Higher Cardiol Therapeutics (TSE:CRDL) Stock Price Up 12.9%April 23, 2024 | markets.businessinsider.comBuy Rating on Cardiol Therapeutics: Projected Blockbuster CardiolRx’s Strategic Advantages and Market PotentialApril 20, 2024 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc Purchase WT up on Tuesday (CRDL-WT-A)April 13, 2024 | seekingalpha.comCRDL:CA Cardiol Therapeutics Inc.February 21, 2024 | finance.yahoo.comCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent PericarditisFebruary 9, 2024 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)February 2, 2024 | finance.yahoo.comIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?January 30, 2024 | morningstar.comCardiol Therapeutics Inc Class ADecember 5, 2023 | finance.yahoo.comCardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-PilotNovember 1, 2023 | proactiveinvestors.comCardiol Therapeutics reaches new milestone in Phase II study for recurrent pericarditisNovember 1, 2023 | finance.yahoo.comCardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent PericarditisOctober 23, 2023 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 11, 2023 | proactiveinvestors.comCardiol Therapeutics releases positive study results of...Cardiol Therapeutics releases positive study results of...October 10, 2023 | benzinga.comCBD To Treat Heart Failure? New Study Shows Its Cardioprotective EffectsSeptember 28, 2023 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 26, 2023 | finance.yahoo.comCardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 19, 2023 | proactiveinvestors.comCardiol Therapeutics on track to complete enrollment for acute myocarditis trial six months ahead of scheduleAugust 16, 2023 | msn.comCardiol Therapeutics Inc. (CRDL) Upgraded to Buy: Here's What You Should KnowJune 6, 2023 | finance.yahoo.comCRDL.TO - Cardiol Therapeutics Inc.May 19, 2023 | investing.comCardiol Therapeutics (CRDL) Earnings Dates & ReportsMay 9, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc down on Monday (CRDL)April 21, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)April 12, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)April 8, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc flat on Thursday (CRDL)April 6, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)April 1, 2023 | uk.finance.yahoo.comCardiol Therapeutics Inc. (CRDL.TO)March 7, 2023 | finance.yahoo.comCardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart FailureFebruary 17, 2023 | seekingalpha.comCRDL Cardiol Therapeutics Inc.January 17, 2023 | proactiveinvestors.comCardiol Therapeutics enrols first patient in Phase 2 study of CardiolRx for Recurrent PericarditisDecember 12, 2022 | finanznachrichten.deCardiol Therapeutics Inc.: Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx for the Treatment of Recurrent PericarditisDecember 12, 2022 | finance.yahoo.comCardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent PericarditisNovember 15, 2022 | finance.yahoo.comCardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementNovember 7, 2022 | finance.yahoo.comCardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute PericarditisOctober 25, 2022 | proactiveinvestors.comCardiol Therapeutics to prioritize its Phase II clinical programs focused on developing CardiolRx for two underserved diseases affecting the heartOctober 25, 2022 | finance.yahoo.comCardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart DiseasesOctober 3, 2022 | proactiveinvestors.comCardiol Therapeutics unveils new preclinical study results providing evidence of cardioprotective properties of CardiolRxOctober 3, 2022 | finance.yahoo.comCardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac FibrosisSeptember 28, 2022 | finance.yahoo.comCardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of AmericaAugust 3, 2022 | proactiveinvestors.comCardiol Therapeutics says first patient enrolled in acute myocarditis trial of its oral cannabinoid formulation CardiolRxAugust 3, 2022 | proactiveinvestors.comCardiol Therapeutics hits major milestone with first patient enrolled in Phase 2 trial of CardiolRXJuly 18, 2022 | finanznachrichten.deFinancialnewsmedia.com: Air Pollution is a Global Heart and Lung Health ConcernJune 29, 2022 | finance.yahoo.comCardiol Therapeutics Reports Results of 2022 Annual General MeetingJune 27, 2022 | finance.yahoo.comCardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDTJune 16, 2022 | proactiveinvestors.comCardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart diseaseJune 7, 2022 | finanznachrichten.deFinancialnewsmedia.com: Breakthroughs In Treating Killer Diseases Could Lengthen LifeJune 7, 2022 | benzinga.comBreakthroughs In Treating Killer Diseases Could Lengthen Life Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address He cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto. Click now for the best way into the newest AI projects CRDL Media Mentions By Week CRDL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.470.55▲Average Medical News Sentiment CRDL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼30▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HLS Therapeutics News Cipher Pharmaceuticals News BioSyent News Organigram News Decibel Cannabis News Aurora Cannabis News Knight Therapeutics News Medicenna Therapeutics News Zentek News Hamilton Thorne News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CRDL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon to Transform U.S. Economy? Porter & CompanyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
